Medical Use
Humira (adalimumab injection) is a TNF blocker used to treat various conditions:
- -Rheumatoid Arthritis (RA): Helps reduce signs and symptoms, induces major clinical response, prevents structural damage progression, and improves physical function in adults with moderately to severely active disease.
- -Psoriatic Arthritis: Reduces signs and symptoms of active arthritis, inhibits structural damage progression, and enhances physical function.
- -Ankylosing Spondylitis: Alleviates signs and symptoms in patients with active disease.
- -Crohn’s Disease: Reduces signs and symptoms, and induces and maintains clinical remission in adults with moderately to severely active disease who have not responded adequately to conventional therapy. It also helps those who have lost response to or cannot tolerate infliximab.
- -Plaque Psoriasis: Treats adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.
Warning & Precautions
Adalimumab 40 mg should not be started in patients with active infections, whether chronic or localized. If a new infection develops during treatment, patients should be closely monitored, and therapy should be discontinued if a serious infection occurs. Before beginning Humira 40 mg injections, patients should be evaluated for tuberculosis risk factors and tested for latent tuberculosis infection.
Prescribers should be cautious when considering Humira for patients with preexisting or recent-onset central nervous system demyelinating disorders. The concurrent use of anakinra and other TNF blockers with Humira 40 mg is not recommended due to an increased risk of serious infections and neutropenia.
Humira therapy may lead to the formation of autoantibodies and, in rare cases, the development of a lupus-like syndrome. If such symptoms appear, discontinuation of Humira is advised.
Documentation Availability
Documents required to import HUMIRA to India?
HUMIRA Injection (Adalimumab) can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii0Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing Humira Injection (Cancer Treatment Medicines) from around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is the Generic Name for the trade name drug Humira® ?
Adalimumab is Generic Name for the trade name drug Humira®.
What is the Manufacturer Name of Humira®?
Humira® is manufactured by Abbott Labs Inc. (ABBVIE).
Is Humira® approved by the FDA?
Yes, Humira® is approved by the FDA. The product was approved in December 2002.
What is the dosage and form of Humira® available?
Humira is available as 1 mL prefilled glass syringe provides 40 mg (0.8 mL) Injection.
How is Humira (Adalimumab) vial supplied?
Each vial of Humira (Adalimumab) contains 40 mg (0.8 ml). The product is available as either a single-use, prefilled humira pen (HUMIRA Injection).
What are the storage conditions of Humira (Adalimumab)?
Humira (Adalimumab) must be refrigerated at 36°F to 46°F (2°C to 8°C). Do not freeze.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
